About Elixir Medical
Elixir Medical is a Healthcare company based in Sunnyvale (United States) founded in 2005. Drug eluting stents. Elixir Medical has raised $5.3 million across 1 funding round from investors including Invus. The company has 70 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity in India is Elixir Medcorp India Private Limited (U33110DL2012FTC230915).
Company details
Elixir Medical, a privately held company headquartered in Sunnyvale, CA, is developing drug-eluting stent systems. Key products include the Novolimus Eluting Stent System and Bioresorbable Coronary Scaffold System. The products are only approved for use outside the US.
- Headquarters Sunnyvale, United States
- Employees 70
- SectorsHealthcare
- Website elixirmedical.com
- Social LinkedIn X
- Legal Name Elixir Medcorp India Private Limited
- Date of Incorporation 02 Feb, 2012
- Jurisdiction New Delhi, Delhi, India
- Total Equity Funding$5.3M (USD)
in 1 rounds
- Latest Funding Round$5.3M (USD), Series A
Mar 2005
- Investors
- Employee Count70
Associated legal entities of Elixir Medical
Elixir Medical operates through Elixir Medcorp India Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elixir Medcorp India Private Limited CIN U33110DL2012FTC230915 | Strike Off | 02 Feb 2012 | New Delhi, Delhi | 2 | View details |
Funding Insights of Elixir Medical
Elixir Medical has successfully raised a total of $5.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.3 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.3M
- Total Rounds 1
- Last Round Series A β $5.3M
- First Round $5.3M
(Mar 2005)
- Investors Count 1
All 1 funding rounds of Elixir Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2005 | $5.3M | Series A | β | β |
1 investors in total: 1 institutional.
Investors in Elixir Medical
Elixir Medical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Invus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Long-term private equity investments in transformational opportunities are pursued. | invus.com | New York, United States |
Investor details for Elixir Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Elixir Medcorp India Private Limited (Elixir Medical)
Elixir Medcorp India Private Limited is the primary company behind Elixir Medical. The board of Elixir Medcorp India Private Limited currently have 2 directors; the longest-serving is Motasim Sirhan, appointed in 2012.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Motasim Sirhan DIN 05107062 | Director | 02 Feb 2012 | 14 yrs 9 mo | Elixir Medcorp India Private Limited |
| Jonas Miguel Fajgenbaum DIN 05107055 | Director | 02 Feb 2012 | 14 yrs 9 mo | Elixir Medcorp India Private Limited |
People of Elixir Medical
35 people are tracked at Elixir Medical (21 in leadership, 14 in team); the tracked headcount is 70.
| Name | Role | Group |
|---|---|---|
Brian McBerry | Director Of Sales Operations And Supply Chain | Leadership |
| Founder & Chief Executive Officer | Leadership | |
Sean Fryman | Associate Director, Quality Engineering | Leadership |
Alex Nepogodiev | Executive Vice President Strategy And Marketing | Leadership |
Vinayak Bhat | President & Chief Operating Officer | Leadership |
Elizabeth Lau Ph.D. | Director Clinical Research | Leadership |
Candace Elek | Executive Vice President, Clinical Research | Leadership |
Sam Omaleki | Sr. Vice President, Operations | Leadership |
Grant Choe | Director Of Marketing | Leadership |
Armando Garza | VP R&d | Leadership |
Erin Mazzone | Vice President, Regulatory And Quality | Leadership |
Ginger Autry | Director Clinical Research | Leadership |
Gretchen Wilderspin | Senior Director Clinical Research | Leadership |
Laurie Moncrief | Vp, Human Resources | Leadership |
John Pustell | Vice President Operations | Leadership |
Germaine Guenard | Vice President Human Resources | Leadership |
Joaquin Azpilicueta | Medical Director | Leadership |
Max Muhs | Executive Regional Vice President | Leadership |
Chris Ryan | Vice President, Commercial Strategy And Execution | Leadership |
Horia Grosu | Sr. Director Of Commercial Operations | Leadership |
15 more people are available in the full profile.
Complete people profiles for Elixir Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elixir Medical
2 dated milestones of Elixir Medical, from founding to its latest funding, stage changes and deals.
- Founded Elixir Medical is founded.
- Funding First funding round of $5.3M.
Web traffic of Elixir Medical
The website of Elixir Medical (elixirmedical.com) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 19% vs previous month
Websites whose visitors overlap most with Elixir Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| allbiomedical.com | 100% | View details | |||
| biotronik.com | 95% | 128.7K | #316,493 | View details | |
| medicaldevice-network.com | 95% | #456,669 | View details | ||
medison.co.il | medison.co.il | 63% | β | ||
| medisonpharma.com | 63% | 3.4K | #5,039,615 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Elixir Medical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Elixir Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elixir Medical
Complete news archive for Elixir Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elixir Medical
Elixir Medical was founded in 2005.
Elixir Medical is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Elixir Medical is a funded company, having raised a total of $5.3M across 1 funding round to date. The company's 1st funding round was a Series A of $5.3M, raised on Mar 2005.
Elixir Medical has 70 employees.
Elixir Medical, a privately held company headquartered in Sunnyvale, CA, is developing drug-eluting stent systems. Key products include the Novolimus Eluting Stent System and Bioresorbable Coronary Scaffold System. The products are only approved for use outside the US.
Elixir Medical has 1 investor. Key investors include Invus.
Elixir Medical operates through Elixir Medcorp India Private Limited.
The legal entities of Elixir Medical currently have 2 directors, including Motasim Sirhan, Jonas Miguel Fajgenbaum.

